GRAM publications
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet, 404, 1199 - 1226
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators None., (2024), Lancet Glob Health, 12, e201 - e216
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators None., (2023), Lancet Reg Health Am, 25
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Antimicrobial Resistance Collaborators None., (2022), Lancet, 400, 2221 - 2248
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators None., (2022), Lancet Public Health, 7, e897 - e913
Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.
Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ. et al, (2021), Lancet Planet Health
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.
Dunachie SJ. et al, (2020), Curr Opin Microbiol, 57, 95 - 101
Recent publications by Researchers affiliated with the GRAM project
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ. et al, (2021), Lancet Planet Health
Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.
Shearer FM. et al, (2018), Lancet Glob Health, 6, e270 - e278
Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline analysis for the Sustainable Development Goals.
Golding N. et al, (2017), Lancet, 390, 2171 - 2182
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis.
Shearer FM. et al, (2017), Lancet Infect Dis, 17, 1209 - 1217
The contemporary distribution of Trypanosoma cruzi infection in humans, alternative hosts and vectors.
Browne AJ. et al, (2017), Sci Data, 4
Mapping the spatial distribution of the Japanese encephalitis vector, Culex tritaeniorhynchus Giles, 1901 (Diptera: Culicidae) within areas of Japanese encephalitis risk.
Longbottom J. et al, (2017), Parasit Vectors, 10